2. PRODUCTO
2.1. Aspectos Generales
2.1.4. Proceso de Cultivo del Plátano
2.1.4.3. Selección de la semilla
134 2/18/2018 HPV Vaccination: A Review of the First Decade, Plenary Talk. 8th PanHellenic HPV
Conference, “HPV Infections and Related Diseases”, Thessaloniki Greece
133 2/18/2018 Cervical Cancer Screening Strategies in the United States, Round Table Talk. 8th
PanHellenic HPV Conference, “HPV Infections and Related Diseases”, Thessaloniki Greece
132 6/14/2013 Cervical Cancer Prevention and Control – Lessons Learned. University of West Indies.
Port of Spain, Trinidad.
131 8/27/2012 How to get all women involved: communication and outreach. Cervical cancer
prevention - the interface of HPV vaccination and screening strategies. Sponsored by the World Health Organization. CTS.1.158. World Cancer Congress 2012, Montreal, Canada.
130 3/30/2012 Mitos y realidades de reacciones adversas de vacunas. Conferencia Magistral (Key Note
Plenary Speaker). Colegio Mexicano de Especialistas en Ginecologia y Obstetricia, A.C.
30 Mar 2012, Mexico City, Mexico.
129 3/30/2012 Progresos en vacunación. Conferencia Magistral (Key Note Plenary Speaker). Colegio Mexicano de Especialistas en Ginecologia y Obstetricia, A.C. 30 Mar 2012, Mexico City, Mexico.
128 3/29/2012 Eficacia de la reacción cruzada vacunación contra VPH. Conferencia Magistral (Key Note
Plenary Speaker). Colegio Mexicano de Especialistas en Ginecologia y Obstetricia, A.C.
29 Mar 2012, Mexico City, Mexico.
127 3/28/2012 Immunology of HPV Infections. Conferencia Magistral (Key Note Plenary Speaker). Colegio Mexicano de Especialistas en Ginecologia y Obstetricia, A.C. 28 Mar 2012, Mexico City, Mexico.
126 7/10/2011 Distance Training in Africa Project: The Sub-Saharan Africa Training Project. Review of
Data supporting cervical cancer screening. Sponsored by the International Federation of Colposcopists and Cervical Pathologists
125 7/10/2011 Distance Training in Africa Project: The Sub-Saharan Africa Training Project. HPV
Vaccines: options for cervical cancer protection in Africa. Sponsored by the International Federation of Colposcopists and Cervical Pathologists
124 7/6/2011 International Federation of Colposcopists and Cervical Pathologists. HPV Vaccination
in older women. Rio de Janiero, Brazil.
123 7/6/2011 International Federation of Colposcopists and Cervical Pathologists. Impact of HPV
vaccines in different income countries. Rio de Janiero, Brazil.
122 7/1/2011 Institute of Medicine of the National Academies. Review of Adverse Events of Vaccines:
Evidence and Causality.
121 6/22/2011 Society of Canadian Colposcopists/Society of Obstetricians and Gynecologists of Canada 25th Annual meeting. Review of Data supporting cervical cancer screening. Vancouver, BC, Canada.
120 6/22/2011 Society of Canadian Colposcopists/Society of Obstetricians and Gynecologists of Canada 25th Annual meeting. HPV Vaccines – Shared Decision Making Implementation – options for cervical cancer protection. Vancouver, BC, Canada.
119 12/4/2010 Wilkonson Women’s Health Lectureship. Interpretation of Pap Smears with Special
Attention to HPV Typing - Reprise. University of Kansas School of Medicine, Wichita, KS.
118 3/8/2010 -
3/15/2010 Wim Schellekens FoundationVisiting Professorship to the Netherlands Lecture series
117 3/10/2010 State of the Art HPV Vaccination. Radboud University Department of Obstetrics and
Gynecology, Nijmegen, the Netherlands.
116 3/9/2010 The Future of Cervical Cancer Screening Prevention. Radboud University, Department
of Obstetrics and Gynecology, Nijmegen, the Netherlands.
115 3/9/2010 Doctoral Examination Board for Charlotte H. Lenselink: Sexual Behaviour and HPV in
young Women. The pre-vaccine era. Council of Deans, Registrar, Radboud Universiteit
Nijmegen, the Netherlands
114 3/9/2010 State of the Art HPV Vaccination. Radboud University Department of Obstetrics and
Gynecology, Nijmegen, the Netherlands.
113 3/9/2010 The Future of Cervical Cancer Screening Prevention. Radboud University, Department
of Obstetrics and Gynecology, Nijmegen, the Netherlands.
112 3/8/2010 Cervical Cancer Screening as Disease Prevalence Decreases. Department of
Gynaecology and Oncology at the Faculty of Health, Medicine and Life Sciences and Research Institute GROW, School for Oncology and Developmental Biology, University of Maastricht/Maastricht University, Medical Center, Maastricht, the Netherlands.
111 3/8/2010 HPV Vaccination as an option for Cervical Cancer Prevention. Department of Obstetrics
and Gynecology, Vie Curie Medical Center, Venlo, the Netherlands.
110 6/4/2007 Council on Foreign Relations, Global Health. Presentation to international stakeholders,
New York City, NY
109 1/28/2006 Ken Hatch Gynecologic Oncology Lectureship. Seminar for Cervical Cancer Prevention.
University of Arizona, Tucson, AZ.
108 10/1/2005 UK National Cancer Research Institute and Cancer Research UK. A Vaccine for Cervical ,
Birmingham UK
107 5/1/2005 John M. Smith, Jr. Visiting Professor. Prevention of Cervical Cancer. University of
Texas Health Sciences Center at San Antonio, San Antonio, TX.
106 12/1/2004 Wilkonson Women’s Health Lectureship. Interpretation of Pap Smears with Special
105 7/11/2012 Harper DM. Review of management strategies for women treated for CIN 3. EuroGin
2012. Prague, Czech Republic
104 7/8/2012 Harper DM. Psycho-social-sexual quality of life of women undergoing cervical cancer
screening. EuroGin 2012. Prague, Czech Republic.
103 6/22/2011 Harper DM. Review of Cervical Cancer Screening. Distance Learning for Africa Course
sponsored by the International Federation of Cervical Pathology and Colposcopy under the direction of Secretary General Walter Prendiville
102 3/19/2011 Harper, DM. Cervarix: HPV Vaccine. Consenso LatinoAmericano de Manejo de las
lesions preinvasoras e invasoras del tracto genital inferior, Toluca Mexico
101 3/19/2011 Harper DM. The Natural History of HPV. Conferencio Magistral Consenso
LatinoAmericano de Manejo de las lesions preinvasoras e invasoras del tracto genital inferior, Toluca Mexico
100 9/16/2010 Harper DM. Prophylactic HPV Vaccines. Conferencio Magistral. Consenso
LatinoAmericano de Manejo de las lesions preinvasoras e invasoras del tracto genital inferior, Toluca Mexico
99 9/15/2010 Harper DM. Prevention Strategies for Cervical Cancer in the HPV Vaccine Era.
Conferencio Magistral. El Cáncer de la Mujer en el Presente Milenio. World Forum on Gynecologic Oncology. Toluca, Mexico
98 9/14/2010 Harper DM. HPV and Anogenital Cancers. Conferencio Magistral. El Cáncer de la Mujer
en el Presente Milenio. World Forum on Gynecologic Oncology. Toluca, Mexico
97 11/24/2009 Harper DM. Epidemiology of HPV in adolescents and its management. Adolescent
Gynecology. Sociedad Chilena de Obstetricia y Ginecologia 70th annual National Conference. Vina del Mar, Chile
96 11/24/2009 Harper DM. Screening in the Vaccine Era. Advanced Gynecologic Oncology. Sociedad
Chilena de Obstetricia y Ginecologia 70th annual National Conference. Vina del Mar, Chile
95 11/23/2009 Harper DM. HPV Vaccines: How to introduce HPV vaccines into the ob/gyn practice:
when, where, which. Basic Gynecologic Oncology. Sociedad Chilena de Obstetricia y Ginecologia National Conference. Vina del Mar, Chile
94 11/23/2009 Harper DM. Impact of HPV Vaccinations. Keynote lecture. Sociedad Chilena de
Obstetricia y Ginecologia National Conference 70th annual meeting. Vina del Mar, Chile.
93 5/26/2008 Harper DM. Magistral Lecture: HPV Vaccination in this era. Society for Gynecologic
Oncologists. Institute Mangiagalli, Milan, Italy.
92 5/22/2008 Harper DM. The basics of molecular diagnostics on cytology samples for
cytopathologists. IX International Workshop of Lower Genital Tract Pathology: HPV disease in the vaccine era, time to retire? Viareggio, Italy.
91 5/22/2008 Harper DM. Prevention of Genital Warts, a Summary to date IX International Workshop
of Lower Genital Tract Pathology: HPV disease in the vaccine era, time to retire? Viarregio, Italy.
90 5/22/2008 Harper DM. Rolling out the HPV vaccines, now or later? IX International Workshop of
Lower Genital Tract Pathology: HPV disease in the vaccine era, time to retire? Viarregio, Italy.
89 5/22/2008 Harper DM. Prophylactic Vaccination: a Summary of clinical data. IX International
Workshop of Lower Genital Tract Pathology: HPV disease in the vaccine era, time to retire? University of Rome, Rome, Italy
88 4/17/2008 Harper DM. HPV vaccination for a new generation of women. Gynecologic Congress.
Buenos Aires, Argentina.
87 3/21/2008 Harper DM. Clinical perspectives on HPV vaccination. Aegean Gynecologic and
Endoscopic Congress. Izmir, Turkey.
86 3/19/2008 Harper DM. Reducing cervical cancer by vaccination in the Middle East. Istanbul,
Turkey.
85 3/17/2008 Harper DM. HPV vaccination for pediatricians. Ankara, Turkey. 84 2/26/2008 Harper DM. HPV Masterclass. Johannesburg, South Africa.
83 2/13/2008 Harper DM. The role of HPV vaccination in women’s health care. Oslo Kongress Senter
Ministries of Health and Social Services, Oslo, Norway.
82 12/6/2007 Harper DM. Future Perspectives in HPV Vaccination. HPV 2007: 57th Annual Meeting of
the German STD Society, Hannover, Germany.
81 11/20/2007 Harper DM. HPV and HPV vaccination. 10th World Congress of Infectious and
Immunological Diseases in Obstetrics and Gynaecology, Urology and Dermatology, Grand Cayman, Cayman Islands.
80 11/14/2007 Harper DM, Bogaerts H. The potential reduction in CIN 2/3 and Cervical Cancer by HPV vaccination. 52nd Brazilian Congress of Gynaecology & Obstetrics, Fortaleza, Brazil. 79 11/12/2007 Harper DM. Clinical Aspects of Prophylactic Vaccines and Trial. 4th Dubai International
Obs-Gyne & Fertility Conference & Exhibition. DIOFCE 2007, Dubai, UAE.
78 11/11/2007 Harper DM. Safety, Efficacy and Immunogenicity of Cervarix. Abu Dhabi, UAE. 77 11/10/2007 Harper DM.The value of cross protection in HPV vaccines. Dubai Society of Obs-Gyne,
Dubai UAE.
76 11/6/2007 Harper DM, Bevington C, Saliba H. Information Accuracy of the HPV Vaccine: US Mass communication campaign one year after regulatory approval. 24th International Papillomavirus Conference and Clinical Workshop. Beijing, China.
75 10/31/2007 Harper DM. Sustained HPV 16 and 18 antibody levels through 5.5 years in women vaccinated with a HPV 16/18 L1 VLP AS04 candidate vaccine.15th International Meeting of the European Society of Gynaecological Oncology, Berlin, Germany.
74 10/20/2007 Harper DM.HPV Vaccines 10 months later: Findings from the bivalent HPV vaccine studies. 9th Congress of the International College of Out-patient Gynaecology & 5th Pan-Hellenic Congress for Colposcopy and Cervical Pathology. Athens, Greece.
73 10/12/2007 Harper DM. Clinical Performance of the bivalent HPV vaccine. Lisbon society of Obs-
Gyne, Lisbon, Portugal.
72 10/5/2007 Harper DM.The Patient Perspective regarding HPV vaccination, Monte Carlo, Monaco. 71 10/4/2007 Harper DM. HPV Vaccine Efficacy: Lessons from clinical trials – Bivalent Vaccine.
EuroGin New Strategies of Cervical Cancer Prevention: The reality of HPV vaccines, Monte Carlo, Monaco.
69 9/3/2007 Harper DM. Preventing Cervical Cancer with Vaccination – a priority for all women. HPV
Forum. Vietnamese Societies of Pediatrics, Obstetrics and Gynecology, Immunology, Tu Du Hospital. Ho Chi Minh City, Vietnam.
68 9/2/2007 Harper DM. Meet the Experts: Drs. Limson, Llave, Sumpaico, Harper. Philippine Society
for CPC. Manila, Philippines.
67 9/2/2007 Harper DM. New adjuvants increase vaccine immunogenicity for longer protection.
Joint Annual Convention of the Society of Gynecologic Oncologist of the Philippines; the Philippine Society for Cervical Pathology and Colposcopy; and the Philippine Society for the Study of Trophoblastic Diseases. Manila, Philippines.
66 9/1/2007 Harper DM. Cervical cancer prevention for all women. Taiwan Association of Obstetrics
and Gynecology, National Taiwan University, Taipei, Taiwan.
65 9/1/2007 Harper DM. The role of vaccination in cervical cancer prevention. Taiwan Assn of
Gynecologic Oncology, Taipei, Taiwan.
64 9/1/2007 Harper DM. The immunogenicity of natural HPV infections. Taiwan Association of
Family Medicine, Taipei, Taiwan.
63 9/1/2007 Harper DM. The Science and Innovation of Cervical Cancer Vaccines. Taiwan Cervical Ca
Prevention Summit, Taipei, Taiwan.
62 8/31/2007 Harper DM. Immunogenicity, Efficacy and Safety of HPV Vaccines. Korean Food & Drug
Administration Viral Vaccines Team Biologics Headquarters. Seoul, Korea.
61 8/31/2007 Harper DM. Innovative Primary Prevention for Cervical Cancer – 5.5 years of evidence.
HPV Academy Symposium and Korean Society of Obstetrics and Gynecology Conference. Seoul, Korea.
60 8/30/2007 Harper DM. The Global Burden of Cervical Cancer and the Hope of HPV Vaccines.
Korean Society of Pediatric Infectious Diseases Conference. Seoul, Korea.
59 8/30/2007 Harper DM. What HPV vaccines cannot do. SISAIN of Korea. Seoul, Korea.
58 8/29/2007 Harper DM. New Paradigm Shift in the Prevention of Cervical Cancer. Obstetrics and
Gynecology Society of Singapore. Singapore.
57 8/28/2007 Harper DM. The Science of HPV Vaccines. Gynecologic Oncology Unit of the University
of Malaysia, Kuala Lumpur, Malaysia.
56 8/28/2007 Harper DM. Immunogenicity of HPV Vaccines for Perimenopausal Women. National
Pharmaceutical Control Bureau, Ministry of Health, Malaysia.
55 8/28/2007 Harper DM. Targeting broad and sustained protection against cervical cancer. General
Practitioners of Malaysia Forum on Protection against Cervical Cancer. Kuala Lumpur, Malaysia.
54 8/25/2007 Harper DM. Cervical cancer vaccination of older women. Philippine Media Society.
Manila, Philippines.
53 8/25/2007 Harper DM. Implementing HPV vaccines: Experience and Guidance. Innovation to
Application: HPV Vaccines. Manila, Philippines.
52 8/25/2007 Harper DM. US perspective on HPV vaccination. Asian Cervical Cancer Prevention
Advisory Board Meeting, Manila, Philippines.
51 8/23/2007 Harper DM. Toll like receptor agonists increase immunogenicity of cervical cancer vaccine. Obstetrics and Gynecology Society of Hong Kong. Hong Kong China.
50 8/23/2007 Harper DM. The relevance of the AS04 adjuvant system to cervical cancer vaccination.
Hong Kong College of Family Physicians, Hong Kong, China.
49 8/11/2007 Harper DM. Cervical Cancer Immunization. 4th Annual Caribe-Gyn Congress, Ponce,
Puerto Rico
48 5/16/2007 Harper DM. Integrating Vaccination with Cervical Cancer Screening Strategies. British
Columbia Cancer Agency, Vancouver, BC, Canada.
47 5/13/2007 Harper DM. HPV Vaccine Puzzle in Cervical Cancer Screening. International Congress of
Cytology, Vancouver, BC, Canada.
46 1/28/2007 Harper DM. HPV MasterClass. Madrid, Spain.
45 12/15/2006 Harper DM. Preventing Cervical Cancer. Deutsches Krebsforschungszentrum Im
Neuenheimer, Heidelberg, Germany. In Honor of Harold Zur Hausen, Nobel Laureate
44 11/30/2006 Harper DM. Preventing Cervical Cancer in the 21st Century. British Society of Gynaecologic Oncology. Manchester, UK.
43 11/17/2006 Harper DM. State-of-the-Art Lecture: Gynaecological Cancer: New approach for the prevention of cervical cancer—HPV vaccines. 13th Hong Kong International Cancer Congress and 3rd Annual Meeting of Centre for Cancer Research, Cheung Kung Hai Conference Centre, Li Ka Shing Faculty of Medicine Building, The University of Hong Kong, Hong Kong, China.
42 11/16/2006 Harper DM. Benefits and limitations of HPV vaccines. Biennial General Meeting, Hong
Kong Society of Colposcopy and Cervical Pathology, Hong Kong, China.
41 11/10/2006 Harper DM. HPV Vaccination for Pediatricians. 50th Turkish National Pediatric Congress
Antalya, Turkey.
40 11/8/2006 Harper DM. Vaccination for Cancer. 5th World Congress on Vaccines, Immunisation and Immunotherapy. Montreal, CA.
39 9/27/2006 Harper DM. The Potential for Cervical Cancer Prevention in Poland. Presented to the
Gynecologic Oncology Society and the Gynecology Society of Poland. Poznan, Poland.
38 9/22/2006 Harper DM. HPV MasterClass, Montreal, Canada.
37 9/7/2006 Harper DM. Cross Protection within HPV vaccines. 2nd Annual Asia-Oceania Research Organisation in Genital Infection and Neoplasia. Cebu, Philippines.
36 9/7/2006 Harper DM. Epidemiology of HPV. 2nd Annual Asia-Oceania Research Organisation in Genital Infection and Neoplasia. Cebu, Philippines.
35 7/23/2006 Harper DM. Update on HPV vaccination guidelines in USA. Asia Pacific Cervical Cancer
Prevention Board Meeting, Bangkok, Thailand.
34 7/22/2006 Harper DM. HPV MasterClass. Bangkok, Thailand.
33 6/28/2006 Harper DM. Childhood Vaccination for an Adult Cancer. 30th Anniversary Mexican
Association of Pediatrics Congress, Mexico City, Mexico.
32 6/27/2006 Harper DM. New alternatives in the prevention of cervical cancer. National Institute of
Pediatrics Mexico City, Mexico.
31 6/25/2006 Harper DM. Social and Sexual Networks of Adolescents Driving Implementation of HPV vaccination Programmes. Presented to the Societie d’Oncologie Gynecologique de Canada. Vancouver, BC, CA
30 6/14/2006 Harper DM.HPV Disease and Its Prevention. 12th International Congress on Infectious Diseases. Lisbon, Portugal.
29 6/14/2006 Harper DM. Understanding Cervical Cancer Prevention. Portuguese Society of
Gynecologic Oncologists. Lisbon, Portugal.
28 5/8/2006 Harper DM. Fighting Cervical Cancer with Cytology Screening and HPV Vaccines.
National Press Club, Washington DC.
27 5/6/2006 Harper DM. HPV Vaccination in the US. ACOG Roundtable Discussion, Washington DC. 26 5/3/2006 Harper DM. Vaccination for Prevention and Treatment of Cervical Cancer. 22nd Annual
Clinical Virology Symposium and Pan American Society for Clinical Virology, Clearwater, FL, USA.
25 4/23/2006 Harper DM. HPV Vaccination. Presented to EuroGin, Paris, France.
24 4/20/2006 Harper DM. Duration of HPV Vaccination. Presented to Society for Gynecologic
Oncology, Antalya, Turkey.
23 4/4/2006 Harper DM. HPV Monograph meeting, Barcelona, Spain.
22 2/24/2006 Harper DM.Social Network Theory to Understand Immunization for HPV. Presented to
the Provincial Health Ministries of Canada, Canadian Association for Immunization Research and Education, Toronto, Ontario, Canada.
21 2/17/2006 Harper DM.Psychosocial Impact of HPV Diseases. Presented to the Pan-Canadian Panel
for HPV Immunization. Montreal, Quebec, Canada.
20 12/2/2005 Harper DM. Chair of Meeting: The Value of Vaccines. HPV Vaccines to Prevent Cervical
Cancer. Prague, Czech Republic.
19 11/5/2005 Harper DM. Vaccination against the Most Common Virally Induced Cancer. 3rd Working
Group Meeting of National Cervical Cancer Consortium, Bureau of Disease Control, Ministry of Health (MOH), Bureau of Women/Children Health, Ministry of Health and China Cancer Research Foundation (CCRF) Beijing CHINA.
18 11/1/2005 Harper DM. Cervical cancer: A review of the disease burden in Europe and the rest of the world. European Cancer Conference Organization (ECCO). Paris, France.
17 10/2/2005 Harper DM. Cancer Cell Biology – Infection and Cancer: A Vaccine for Cervical Cancer.
UK National Cancer Research Institute. Birmingham UK.
16 6/2/2005 Harper DM. HPV Vaccine Implementation. Neue Perspektiven Neue Standards.
Interdisziplinares Symposium zur Pravention, Diagnostikk und Therapie von HPV- induzierten Erkrankungen des unteren Genitaltrakts. Hannover, Germany.
15 5/1/2005 Harper DM. Optical Discrimination of Cervical Tissue in the 21st Century. International HPV 2005 Conference, Vancouver, BC, Canada.
14 5/1/2005 Harper DM. How HPV Affects the Male Partner. International HPV 2005 Conference,
Vancouver, BC, Canada.
13 1/27/2005 Harper DM. Public Health Implementation Strategies of HPV Vaccines. Provincial Health
Ministries of Canada, Canadian Association for Immunization Research and Education (CAIRE), Vancouver, British Columbia, Canada.
12 10/23/2004 Harper DM. New Methods of HPV Screening and Management EuroGin 2004, Nice
France – Expert Discussion Panels: 6th International Multidisciplinary Congress: EuroGin, Cité des Sciences et de l’Industrie, Workshop 11. Paris, France
11 10/21/2004 Harper DM. Recent Progress in HPV Vaccines EuroGin 2004, Nice France – Expert
Discussion Panels: 6th International Multidisciplinary Congress: EuroGin, Cité des Sciences et de l’Industrie, Workshop 2. Paris France
10 10/23/2004 Harper DM. Public Health Issues of Cervical Cancer Control EuroGin 2004, Nice France –
Expert Discussion Panels: 6th International Multidisciplinary Congress: EuroGin, Cité des Sciences et de l’Industrie, Plenary session 4. Paris, France
9 10/22/2004 Harper DM. Cervical Cancer Screening management protocols: Shared decision making in the US - The NCI Experience EuroGin 2004,– Expert Keynote Addresses: 6th
International Multidisciplinary Congress: EuroGin, Paris, Cité des Sciences et de l’Industrie, Plenary session 3. Nice France
8 10/21/2004 Harper DM. Spectrophotometric Identification of cervical disease EuroGin 2004, Nice
France – Expert Keynote Addresses: 6th International Multidisciplinary Congress: EuroGin, Cité des Sciences et de l’Industrie, Plenary session 1. Paris France
7 2/1/2004 Harper DM. HPV Vaccine Symposium II. Keynote Speaker. HPV 16/18 Bivalent L1 VLP
Vaccine Efficacy Study. 21st International HPV Conference, Mexico City, Mexico.
6 4/11/2003 Harper DM. Optical Detection of Cervical Intraepithelial Neoplasia using Fluorescence Spectroscopy. Share the Health Foundation 15th Annual International Conference, Scottsdale AZ.
5 4/11/2003 Harper DM. Self-Sampling for HPV: Its Use in the 21st Century. Share the Health Foundation 15th Annual International Conference, Scottsdale AZ,
4 4/13/2003 Harper DM. What are Health Economic Outcomes and How Are They Adjusted for Quality of Life? 5th International Multidisciplinary Congress: EuroGin, Cité des Sciences et de l’Industrie. Paris France
3 4/13/2003 Harper DM. Cytopathology Course, Interactive Case Studies. 5th International Multidisciplinary Congress: EuroGin, Cité des Sciences et de l’Industrie. Paris France
2 11/1/2000 Harper DM,US Pap smear screening practices - 2000. 3M Global Dysplasia Workshop.
Rome, Italy.
1 11/1/1998 Harper DM, Ganiats T. Cost Effectiveness in Medicine. Workshop presented to the
North American Primary 77Care Research Group (NAPCRG) Annual Meeting. Montreal, Canada.